Lorlatinib 13CD3

SZ目录编号:	SZ-L054D01
CAS 号	NA
分子式	C2013CH16D3FN6O2
分子量	410.4
投资状态	Custom Synthesis
Rel. CAS No	1454846-35-5 (Unlabelled)

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: (R)-26-amino-55-fluoro-11,4-dimethyl-7-(methyl-13C-d3)-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: N#CC(N1C)=C(C(CN(C(C2=CC=C(F)C=C32)=O)[13C]([2H])([2H])[2H])=N1)C4=CN=C(N)C(O[C@@H]3C)=C4

Lorlatinib 13CD3 is chemically (R)-26-amino-55-fluoro-11,4-dimethyl-7-(methyl-13C-d3)-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile. Lorlatinib 13CD3 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib 13CD3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Lorlatinib 13CD3

Contacts

Our Locations

SZ目录编号:	: SZ-L054D01
CAS 号	: NA
分子式	: C2013CH16D3FN6O2
分子量	: 410.4
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-L054001
CAS 号	: 1454846-35-5
分子式	: C21H19FN6O2
分子量	: 406.4
投资状态	: In Stock

SZ目录编号:	: SZ-L054002
CAS 号	: NA
分子式	: C43H36F2N14O6
分子量	: 882.8
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-L054003
CAS 号	: NA
分子式	: C43H37F2N13O5
分子量	: 853.9
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-L054004
CAS 号	: NA
分子式	: C21H20FN7O4
分子量	: 453.4
投资状态	: Custom Synthesis

Lorlatinib 13CD3